These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 15330686)

  • 21. The pharmacological properties of antidepressants.
    Racagni G; Popoli M
    Int Clin Psychopharmacol; 2010 May; 25(3):117-31. PubMed ID: 20305568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depression and antidepressants: molecular and cellular aspects.
    Lanni C; Govoni S; Lucchelli A; Boselli C
    Cell Mol Life Sci; 2009 Sep; 66(18):2985-3008. PubMed ID: 19521663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropeptide and sigma receptors as novel therapeutic targets for the pharmacotherapy of depression.
    Paschos KA; Veletza S; Chatzaki E
    CNS Drugs; 2009 Sep; 23(9):755-72. PubMed ID: 19689166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Designing new treatments for depression and anxiety.
    Chen Z; Yang J; Tobak A
    IDrugs; 2008 Mar; 11(3):189-97. PubMed ID: 18311656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental medication treatment approaches for depression.
    Ionescu DF; Papakostas GI
    Transl Psychiatry; 2017 Mar; 7(3):e1068. PubMed ID: 28323287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review.
    Millan MJ
    Eur J Pharmacol; 2004 Oct; 500(1-3):371-84. PubMed ID: 15464046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The future of depression psychopharmacology.
    Belmaker RH
    CNS Spectr; 2008 Aug; 13(8):682-7. PubMed ID: 18704023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Theory of active antidepressants: a nonsynaptic approach to the treatment of depression.
    Kiss JP
    Neurochem Int; 2008 Jan; 52(1-2):34-9. PubMed ID: 17507113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.
    Herpfer I; Lieb K
    CNS Drugs; 2005; 19(4):275-93. PubMed ID: 15813642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressants: current strategies and future opportunities.
    Uppal A; Singh A; Gahtori P; Ghosh SK; Ahmad MZ
    Curr Pharm Des; 2010; 16(38):4243-53. PubMed ID: 21208177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Depression and neuroplasticity. Interaction of nervous, endocrine and immune systems].
    Cassano P; Argibay P
    Medicina (B Aires); 2010; 70(2):185-93. PubMed ID: 20447905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of action of St John's wort in depression : what is known?
    Butterweck V
    CNS Drugs; 2003; 17(8):539-62. PubMed ID: 12775192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathobiological targets of depression.
    Chopra K; Kumar B; Kuhad A
    Expert Opin Ther Targets; 2011 Apr; 15(4):379-400. PubMed ID: 21254923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The immune system, depression and the action of antidepressants.
    Leonard BE
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 May; 25(4):767-80. PubMed ID: 11383977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficiency of antidepressant drugs as monoamine reuptake inhibitors: analysis of the hydrophobicity influence using biopartitioning micellar chromatographic data.
    Quiñones-Torrelo C; Sagrado S; Villanueva-Camañas RM; Medina-Hernández MJ
    Biomed Chromatogr; 2004 Sep; 18(7):427-35. PubMed ID: 15340967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging drugs for major depressive disorder.
    Kennedy SH; Rizvi SJ
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):439-53. PubMed ID: 19637989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
    Hoyer D; Bartfai T
    Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Classification of the antidepressants (author's transl)].
    Lôo H; Cuche H
    Encephale; 1979; 5(5 Suppl):591-603. PubMed ID: 44866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurogenesis along the septo-temporal axis of the hippocampus: are depression and the action of antidepressants region-specific?
    Tanti A; Belzung C
    Neuroscience; 2013 Nov; 252():234-52. PubMed ID: 23973415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.